Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Wesana Health Hldgs Inc (OP: WSNAF ) 0.0134 -0.0021 (-13.55%) Streaming Delayed Price Updated: 9:51 AM EDT, Jun 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,000 Open 0.0134 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0155 Today's Range 0.0134 - 0.0134 52wk Range 0.0028 - 0.0580 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More July 11, 2023 First Country Allowing MDMA & Psilocybin For Depression, PTSD Makes Headlines On Saturday, July 1, 2023, Australia became the first country to allow physicians to prescribe MDMA to treat post-traumatic... Via Benzinga Wesana Shareholders Vote For Psilocybin And CBD Therapy Asset Sales To Lucy Scientific June 12, 2023 Psychedelics drug developer Wesana Health Holdings Inc. (OTCQB: WSNAF) announced all matters discussed at the company’s annual general and special shareholders meeting of June 9 were approved by a... Via Benzinga Performance YTD +152.83% +152.83% 1 Month +8.94% +8.94% 3 Month -1.47% -1.47% 6 Month +81.08% +81.08% 1 Year -72.14% -72.14% More News Read More Disney, Amgen, First Republic, Psychedelics: How One CEO's Universal Deal-Making Approach Shapes Industries June 05, 2023 Via Benzinga EXCLUSIVE: Infrastructure Built For Healing: 'Consolidation And Legitimacy Are Crucial For Psychedelic Industry Growth' April 13, 2023 Via Benzinga What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry April 03, 2023 Via Benzinga High-Profile Highs: How Celebrity Advocacy Is Transforming Society's Views On Psychedelics And Cannabis March 29, 2023 Via Benzinga Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More March 27, 2023 Via Benzinga Lucy Scientific Shares Trading Higher On Asset Purchase Agreement Of Psychedelic Assets From Wesana Health March 21, 2023 Via Benzinga NGOs Raise Money To Help Stem Opioid Addiction With Psychedelics Program October 19, 2022 Via Benzinga Wesana Sells Clinic Management Services Organization To Strengthen Assets September 02, 2022 Via Benzinga 4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed August 30, 2022 Via Benzinga Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved April 25, 2022 Via Benzinga Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage April 25, 2022 Via Benzinga Daniel Carcillo Explains How Wesana Health Is Using Psychedelics To Treat Traumatic Brain Injury April 20, 2022 Via Benzinga EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space April 19, 2022 Via Benzinga Wesana Health One Step Closer To Clinical Trials Of Psilocybin And CBD Based Treatment Of Brain Injury Related MDD March 14, 2022 Via Benzinga Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS January 18, 2022 Via Benzinga Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana January 11, 2022 Via Benzinga The Legacy Of Dr. Aaron Beck, Father Of Cognitive Therapy, Lives On In Psychedelic Medicine November 04, 2021 Via Benzinga Topics Death Exposures Death Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 Via Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Via Benzinga Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial September 20, 2021 Via Benzinga Can MDMA Treat Traumatic Brain Injury? $1.5 Million Are Being Committed To Finding Out September 14, 2021 Via Benzinga Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M August 16, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
